Maurizio Callari

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

May, 2025

Maurizio Callari

Mar 6, 2025, 10:57 | Science

Armando Orlandi: NA-PHER2 study shows HER2+/ER+ breast cancers can be treated without chemotherapy

Armando Orlandi, Medical Oncologist at Agostino Gemelli University Policlinic, shared an article by Maurizio Callari,…

Mar 6, 2025, 08:16 | Science

Armando Orlandi: Key predictors of response to chemotherapy-free regimens in HER2+/ER+ breast cancer

Armando Orlandi, Medical Oncologist at Agostino Gemelli University Policlinic, shared an article by Maurizio Callari,…

Sep 25, 2024, 13:30 | Blog

Matteo Dugo: Neoadjuvant atezolizumab plus chemotherapy in TNBC

Matteo Dugo shared a post on LinkedIn, about recent paper published in Clinical Cancer Research:…

Jul 24, 2024, 00:59 | Insight

Luca Licata: The fate of immunotherapy trials in breast cancer

Marco Mariani, Resident in Medical Oncology at San Raffaele Scientific Institute, shared a post on X…

All: 4 Posts: 1 - 100

'

Who From Oncology is Featured in TIME100 Health 2025?

'

Francesco Acerbi and Testicular Cancer: The Defender's Fight and Triumphant Return to Football

'

Yvonne Award for Breakthrough Research 2024 Recipient to Time100 Health List

'

Dr Saunthari Somasundaram is the new President-Elect of the NCD Alliance

'

Does Plastic Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023